Security Snapshot

UBS AG - ETRACS UBS BLOOM (UCIB) Institutional Ownership

CUSIP: 90274D390

13F Institutional Holders and Ownership History from Q4 2016 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

11

Shares (Excl. Options)

591,148

Price

$32.97

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / ETRACS UBS BLOOM
Symbol
UCIB on NYSE
Price per share
$32.97
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
591,148
Total reported value
$19,487,900
% of total 13F portfolios
0%
Share change
+79,886
Value change
+$2,634,039
Number of holders
11
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • UCIB - UBS AG - ETRACS UBS BLOOM is tracked under CUSIP 90274D390.
  • 11 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 10 to 11 between Q4 2025 and Q1 2026.
  • Reported value moved from $14,348,158 to $19,487,900.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 11 institutions filings for Q1 2026.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 90274D390?
CUSIP 90274D390 identifies UCIB - UBS AG - ETRACS UBS BLOOM in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.

As of 31 Mar 2026, 11 institutional investors reported holding 591,148 shares of UBS AG - ETRACS UBS BLOOM (UCIB).

Institutional Holders of UBS AG - ETRACS UBS BLOOM (UCIB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 591,148 $19,487,900 +$2,634,039 $32.97 11
2025 Q4 511,262 $14,348,158 +$203,100 $28.06 10
2025 Q3 504,025 $13,696,475 +$1,052,878 $27.17 10
2025 Q2 465,672 $12,274,694 +$646,564 $26.36 10
2025 Q1 441,143 $11,714,641 +$558,347 $26.56 10
2024 Q4 420,533 $10,781,901 -$281,225 $25.76 9
2024 Q3 431,155 $11,199,610 -$1,748,702 $25.97 11
2024 Q2 498,344 $13,006,906 +$554,464 $26.10 12
2024 Q1 477,102 $12,168,742 +$203,160 $25.51 10
2023 Q4 471,604 $11,395,824 +$755,776 $24.16 11
2023 Q3 423,786 $10,764,611 -$448,882 $25.40 7
2023 Q2 442,243 $10,373,184 -$569,009 $23.45 8
2023 Q1 466,493 $11,342,321 +$496,621 $24.32 8
2022 Q4 445,765 $11,020,853 -$2,824,782 $24.72 9
2022 Q3 563,852 $12,804,000 -$306,967 $22.71 11
2022 Q2 572,947 $13,907,000 +$1,523,340 $24.27 12
2022 Q1 510,161 $13,192,000 -$44,438 $25.86 10
2021 Q4 514,220 $10,752,000 -$243,861 $20.91 11
2021 Q3 525,880 $10,541,000 -$1,027,322 $20.04 11
2021 Q2 577,126 $11,158,000 -$15,004 $19.33 10
2021 Q1 579,429 $9,778,000 -$681,045 $16.87 9
2020 Q4 619,820 $9,438,000 -$381,402 $15.23 7
2020 Q3 462,917 $6,154,000 -$72,837 $13.30 7
2020 Q2 468,375 $5,727,000 +$1,739,003 $12.24 6
2020 Q1 327,242 $3,584,000 +$3,584,000 $10.93 6
2017 Q4 0 $0 -$181,000 $32.97 0
2017 Q3 12,870 $181,000 +$181,000 $14.06 1
2017 Q1 0 $0 -$32,000 $32.97 0
2016 Q4 2,300 $32,000 +$32,000 $13.91 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .